These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9798017)
1. Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences. Joly V; Carbon C Clin Infect Dis; 1998 Oct; 27(4):692-4. PubMed ID: 9798017 [No Abstract] [Full Text] [Related]
2. Candida albicans endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Kuehnert MJ; Clark E; Lockhart SR; Soll DR; Chia J; Jarvis WR Clin Infect Dis; 1998 Oct; 27(4):688-91. PubMed ID: 9798016 [TBL] [Abstract][Full Text] [Related]
3. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients. Kelly SL; Lamb DC; Kelly DE; Loeffler J; Einsele H Lancet; 1996 Nov; 348(9040):1523-4. PubMed ID: 8942815 [No Abstract] [Full Text] [Related]
4. Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay. Sweeney JF; Greene JN; Hiemenz JW; Wei S; Rosemurgy AS; Djeu JY J Infect; 1996 Nov; 33(3):221-6. PubMed ID: 8945714 [TBL] [Abstract][Full Text] [Related]
5. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis. Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso). Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462 [TBL] [Abstract][Full Text] [Related]
7. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis]. Kutsyk RV; Pavliuk TD Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159 [TBL] [Abstract][Full Text] [Related]
8. Prosthetic valve endocarditis due to Candida albicans treated successfully with medical treatment alone. Noguchi M; Takai H; Eishi K; Atogami S Jpn J Thorac Cardiovasc Surg; 2004 Jun; 52(6):318-21. PubMed ID: 15242089 [TBL] [Abstract][Full Text] [Related]
9. Early surgical intervention and optimal medical treatment for Candida parapsilosis endocarditis. Toyoda S; Tajima E; Fukuda R; Masawa T; Inami S; Amano H; Arikawa T; Yoshida A; Hishinuma A; Inoue T Intern Med; 2015; 54(4):411-3. PubMed ID: 25748958 [TBL] [Abstract][Full Text] [Related]
10. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. Louie A; Kaw P; Banerjee P; Liu W; Chen G; Miller MH Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745 [TBL] [Abstract][Full Text] [Related]
11. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278 [TBL] [Abstract][Full Text] [Related]
12. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains. Panizo MM; Reviákina V; Dolande M; Selgrad S Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308 [TBL] [Abstract][Full Text] [Related]
13. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units]. Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665 [TBL] [Abstract][Full Text] [Related]
14. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Dagi HT; Findik D; Senkeles C; Arslan U Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756 [TBL] [Abstract][Full Text] [Related]
15. Drug resistance in Candida albicans and Candida glabrata. Kerridge D; Fasoli M; Wayman FJ Ann N Y Acad Sci; 1988; 544():245-59. PubMed ID: 3063171 [No Abstract] [Full Text] [Related]
16. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006. Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ; Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773 [TBL] [Abstract][Full Text] [Related]
17. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans. Khan MS; Malik A; Ahmad I Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200 [TBL] [Abstract][Full Text] [Related]
18. Experimental endocarditis. IV. Tricuspid and aortic valve infection with Candida albicans in rabbits. Freedman LR; Johnson ML Yale J Biol Med; 1972 Apr; 45(2):163-75. PubMed ID: 4553568 [No Abstract] [Full Text] [Related]
19. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis. Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222 [TBL] [Abstract][Full Text] [Related]
20. [Susceptibility of yeasts to antifungal agents in Kaunas University of Medicine Hospital]. Skrodeniene E; Dambrauskiene A; Vitkauskiene A Medicina (Kaunas); 2006; 42(4):294-9. PubMed ID: 16687901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]